Early Versus Late Referral for Catheter Ablation of Ventricular Tachycardia in Patients With Structural Heart Disease

Schron, 2002, Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks, Circulation, 105, 589, 10.1161/hc0502.103330 Moss, 2004, Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator, Circulation, 110, 3760, 10.1161/01.CIR.0000150390.04704.B7 Poole, 2008, Prognostic importance of defibrillator shocks in patients with heart failure, N Engl J Med, 359, 1009, 10.1056/NEJMoa071098 Sweeney, 2010, Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients, Heart Rhythm, 7, 353, 10.1016/j.hrthm.2009.11.027 Moss, 2002, Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction, N Engl J Med, 346, 877, 10.1056/NEJMoa013474 Santangeli, 2016, Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: a systematic review and meta-analysis of randomized controlled trials, Heart Rhythm, 13, 1552, 10.1016/j.hrthm.2016.03.004 Sapp, 2016, Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs, N Engl J Med, 375, 111, 10.1056/NEJMoa1513614 Packer, 2009, Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial [published correction appears in Circulation 2010;121:e39], Circulation, 120, 2170, 10.1161/CIRCULATIONAHA.109.853689 Bardy, 2005, Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure [published correction appears in N Engl J Med 2005;352:2146], N Engl J Med, 352, 225, 10.1056/NEJMoa043399 Connolly, 2006, Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial, JAMA, 295, 165, 10.1001/jama.295.2.165 Martin, 1988, Amiodarone pulmonary toxicity: recognition and pathogenesis (part 2), Chest, 93, 1242, 10.1378/chest.93.6.1242 Aliot, 2009, Heart Rhythm, 6, 886, 10.1016/j.hrthm.2009.04.030 Frankel, 2011, Ventricular tachycardia ablation remains treatment of last resort in structural heart disease: argument for earlier intervention, J Cardiovasc Electrophysiol, 22, 1123, 10.1111/j.1540-8167.2011.02081.x Dinov, 2014, Early referral for ablation of scar-related ventricular tachycardia is associated with improved acute and long-term outcomes: results from the Heart Center of Leipzig ventricular tachycardia registry, Circ Arrhythm Electrophysiol, 7, 1144, 10.1161/CIRCEP.114.001953 Knobloch, 2011, Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias, J Craniomaxillofac Surg, 39, 91, 10.1016/j.jcms.2010.11.001 Kumar, 2015, Role of alternative interventional procedures when endo- and epicardial catheter ablation attempts for ventricular arrhythmias fail, Circ Arrhythm Electrophysiol, 8, 606, 10.1161/CIRCEP.114.002522 Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analyses. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed April 12, 2016. Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, BMJ, 339, 10.1136/bmj.b2535 DerSimonian, 1986, Meta-analysis in clinical trials, Control Clin Trials, 7, 177, 10.1016/0197-2456(86)90046-2 Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, BMJ, 315, 629, 10.1136/bmj.315.7109.629 Romero, 2017, Impact of anti-arrhythmic drug failures before referral on outcomes following catheter ablation of ventricular tachycardia, Heart Rhythm, 14, PO03 Lunati, 2006, Clustering of ventricular tachyarrhythmias in heart failure patients implanted with a biventricular cardioverter defibrillator, J Cardiovasc Electrophysiol, 17, 1299, 10.1111/j.1540-8167.2006.00618.x Dorian, 2004, Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator, Circulation, 110, 3646, 10.1161/01.CIR.0000149240.98971.A8 Hsieh, 2013, Evolution of ventricular tachycardia and its electrophysiological substrate early after myocardial infarction: an ovine model, Circ Arrhythm Electrophysiol, 6, 1010, 10.1161/CIRCEP.113.000348 Roy, 1986, Long-term reproducibility and significance of provokable ventricular arrhythmias after myocardial infarction, J Am Coll Cardiol, 8, 32, 10.1016/S0735-1097(86)80088-2 Della Bella, 2013, Management of ventricular tachycardia in the setting of a dedicated unit for the treatment of complex ventricular arrhythmias: long-term outcome after ablation, Circulation, 127, 1359, 10.1161/CIRCULATIONAHA.112.000872